| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
| 04/29/2004 | US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 04/29/2004 | US20040082597 Use of CRF antagonists and related compositions |
| 04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
| 04/29/2004 | US20040082591 Psychological disorders; antidepressants; anxiolytic agents; eating disorders; sleep disorders; gastrointestinal disorders; cardiovascular disorders |
| 04/29/2004 | US20040082589 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 04/29/2004 | CA2588083A1 Selective androgen receptor modulators and methods of use thereof |
| 04/29/2004 | CA2502355A1 Halogenated selective androgen receptor modulators and methods of use thereof |
| 04/29/2004 | CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | CA2500320A1 Novel compounds with antibacterial activity |
| 04/29/2004 | CA2500083A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 04/29/2004 | CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/28/2004 | EP1413306A1 Tetrahydroquinoline derivatives as CRTH2 antagonists |
| 04/28/2004 | EP1412349A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists |
| 04/28/2004 | EP1412333A1 Biphenyl-substituted 4-hydroxy-quinolones and their use as pesticides and herbicides |
| 04/28/2004 | EP1412332A1 Quinoline derivatives and use thereof as antitumor agents |
| 04/28/2004 | EP1412326A1 Butyric acid derivatives |
| 04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | EP0937045B1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 04/28/2004 | EP0558648B1 Improved matrix metalloprotease inhibitors |
| 04/28/2004 | EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them |
| 04/28/2004 | CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 04/28/2004 | CN1491944A 5-amino-8-methoxy quinolone carboxylic acid derivatives and its preparation |
| 04/28/2004 | CN1491937A 农药 Pesticide |
| 04/28/2004 | CN1147758C Photosensitive quinolone compounds and process of preparation |
| 04/28/2004 | CN1147475C Process for preparation of anti-malarial drugs |
| 04/28/2004 | CN1147459C Galcium receptor-active compound |
| 04/27/2004 | US6727262 Dichlorinated heterocyclic compounds and methods of synthesis |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727248 Substituted quinolinecarboxamides as antiviral agents |
| 04/22/2004 | WO2004033423A2 Anticancer compounds |
| 04/22/2004 | WO2004033419A1 Sulfonamides having antiangiogenic and anticancer activity |
| 04/22/2004 | WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 04/22/2004 | WO2004032848A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 04/22/2004 | WO2003096965A3 Use of quinoline derivatives with anti-integrase effect and applications thereof |
| 04/22/2004 | WO2003041728A9 Novel phenyl-propargylether derivatives |
| 04/22/2004 | US20040077890 Complexed compounds and use thereof for the polymerisation of olefins |
| 04/22/2004 | US20040077867 Amine compounds, their production and use |
| 04/22/2004 | US20040077866 2-Cyclopropyl-4-(4'-fluorophenyl)quinoline-3-carboxyaldehyde made by reacting 3-cyclopropyl-3-oxopropanenitrile with 2-amino-4'- fluorobenzophenone, and reducing the obtained 2-cyclopropyl-4-(4'- fluorophenyl)quinoline-3-carbonitrile |
| 04/22/2004 | US20040077861 Asymmetric addition of organometallic compounds to chiral sulfinimine to give adducts in predominantly one diastereomer can subsequently be transferred into pure enantiomers of by cleavage of the chiral auxilliary |
| 04/22/2004 | US20040077658 Respiratory system, nervous system, brain, gastrointestinal and psychological disorders; chronic obstructive pulmonary disease; antiasthmatics, analgesics |
| 04/22/2004 | US20040077657 HT3 Receptor antagonists; amyotrophic lateral sclerosis, premenstrual tension, obsessive-compulsive disorder; Parkinson*s, Alzheimer*s, and Huntington*s disease; memory, eating, psychological, and nervous system disorders |
| 04/22/2004 | US20040077656 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents |
| 04/22/2004 | US20040077646 Indole nitriles |
| 04/22/2004 | US20040077644 Administering quinoline derivative as analgesic |
| 04/22/2004 | US20040077628 Melanin-concentrating hormone antagonist |
| 04/22/2004 | US20040076633 Genetic vaccines comprising a 1H-imidazo(4,5-c)- 4-amine derivative as an adjuvant, for increasing immune responses in a mammal to the encoded antigen |
| 04/22/2004 | US20040075096 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 04/22/2004 | CA2501901A1 Anticancer compounds |
| 04/22/2004 | CA2501520A1 Sulfonamides having antiangiogenic and anticancer activity |
| 04/22/2004 | CA2500582A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 04/21/2004 | EP1411046A1 QUINOLINE DERIVATIVE AND QUINAZOLINE DERIVATIVE INHIBITING SELF−PHOSPHORYLATION OF HEPATOCYTUS PROLIFERATOR RECEPTOR, AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| 04/21/2004 | EP1409468A2 Guanidinobenzamides as mc4-r agonists |
| 04/21/2004 | EP1409456A2 Detection of transmembrane potentials by optical methods |
| 04/21/2004 | EP1408970A1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment |
| 04/21/2004 | EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/21/2004 | EP1187828B1 Quinoline derivatives as antibacterials |
| 04/21/2004 | CN1491237A Complexed compounds and use thereof for polymerization of olefins |
| 04/21/2004 | CN1491215A Process for producing quinoline carboxyaldehyde derivative and intermediate thereof |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1146557C Process for prepn. of 1-type sodium-hydrogen exchange agent inhibitor |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/21/2004 | CN1146536C Cycloethylene derivatives |
| 04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |
| 04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
| 04/15/2004 | WO2004031138A1 Novel sulphones for inhibition of gamma secretase |
| 04/15/2004 | WO2004030629A2 Novel neurokinin antagonists and methods of use thereof |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | US20040073034 Process for producing quinoline-3-carboxylic acid compound |
| 04/15/2004 | US20040073030 Process for the preparation of quinolone derivatives |
| 04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| 04/15/2004 | US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040072802 Antiarthritic agents; antiulcer agents; bone disorders; antitumor agents; oral diseases |
| 04/15/2004 | US20040072761 Heterocyclicsulfonamide hepatitis C virus inhibitors |
| 04/15/2004 | CA2500966A1 Novel sulphones for inhibition of gamma secretase |
| 04/14/2004 | EP1408037A1 Novel diarylmethylpiperazine and diarylmethylphenyl compounds with analgesic effect |
| 04/14/2004 | EP1408033A1 Dibenzocycloheptene compound |
| 04/14/2004 | EP1406884A1 Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406628A1 Tetrahydroquinoline derivatives |
| 04/14/2004 | EP1406619A1 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 04/14/2004 | EP1406605A1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 04/14/2004 | EP1406572A2 Pediatric formulation of gatifloxacin |
| 04/14/2004 | EP1073662B1 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives |
| 04/14/2004 | EP1040097B1 Potassium channel openers |
| 04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
| 04/14/2004 | CN1489579A 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1489458A Inhibitors against the production and releaseof inflammator cytokines |
| 04/14/2004 | CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same |
| 04/14/2004 | CN1145610C Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 04/13/2004 | US6720344 Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants |